Compounds of formula II are described:
wherein D, n, R
a
, R
b
, and R
c
are as herein defined, along with pharmaceutical compositions and methods of using compounds of formula II for treating or reducing the risk of peritoneal carcinomatosis in a patient.
描述了
化学式II的化合物:其中D、n、Ra、Rb和Rc的定义如本文所述,以及使用
化学式II的化合物治疗或减少患者腹膜癌转移风险的药物组合物和方法。